Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Careium
OM:CARE Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Careium
Popular
Undervalued
Overvalued
Careium
WA
Analyst Price Target
Consensus Narrative from 1 Analyst
ADDA 2025 Delays May Impact Sales, Yet Global Expansion And i-Care Center Could Strengthen Future Prospects
Key Takeaways Dependence on ADDA 2025 and Swedish market competition may delay customer decisions and contract, impacting sales and revenue growth. Expansion efforts and R&D investments risk increased costs and immediate financial strain without guaranteed immediate revenue offset.
View narrative
SEK 30.50
FV
14.4% overvalued
intrinsic discount
8.14%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Your Valuation for
CARE
Careium
Your Fair Value
SEK
Current Price
SEK 34.90
9.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-11m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 1.3b
Earnings SEK 85.3m
Advanced
Set as Fair Value